WonKimMD

PubMed

• 5 citations
  Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
  Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yun...> ;Science. 2024 Feb 2
• 2 citations
  Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms.
  Andrew J Dunbar, Robert L Bowman, Young C Park, Kavi O'Connor, Franco Izzo, Robert M Myers, Abdul Karzai, Zach Zaroogian, Won Jun Kim, Ines Fernandez-Maestre, Michael ...> ;Cancer Discovery. 2024 Jan 12
• 14 citations
  Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia.
  Eric Wang, Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl, Simon J Hogg, Jan Phillipp Bewersdorf, Cuijuan Han, Michael E Singer, Da...> ;Cancer Cell. 2023 Jan 9
• 10 citations
  Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
  Sisi Chen, Rahul S Vedula, Antonio Cuevas-Navarro, Bin Lu, Simon J Hogg, Eric Wang, Salima Benbarche, Katherine Knorr, Won Jun Kim, Robert F Stanley, Hana Cho, Carolin...> ;Cancer Discovery. 2022 Oct 5
• 18 citations
  Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer.
  Rahul Aggarwal, Nicholas R. Rydzewski, Li Zhang, Adam Foye, Won Kim, Kyle T Helzer, Hamza Bakhtiar, S. Laura Chang, Marc D. Perry, Martin E. Gleave, Robert E. Reiter, ...> ;JAMA Oncology. 2021 Nov 1
• 1 citations
  A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A ...
  YaoYao Pollock, Li Zhang, Stacey A. Kenfield, Erin L. Van Blarigan, Tammy J. Rodvelt, Michael W. Rabow, Greta Macaire, Rami Weinberg, Kimberly S. Topp, Terence W. Frie...> ;Urologic Oncology. 2021 Oct 1
• 15 citations
  Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study.
  Mina Lee, Haemin Hong, Won Kim, Li Zhang, Terence W. Friedlander, Lawrence Fong, Amy M. Lin, Eric J. Small, Xiao X. Wei, Tammy J. Rodvelt, Brigid Miralda, Brian Stocks...> ;Clinical Genitourinary Cancer. 2019 Feb 1
• 83 citations
  Erratum: Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer (Cell (2018) 174(3) (758–769.e9), (S0092867418308420) (10.1016/j.cell.2018.06.039))
  David A. Quigley, Ha X. Dang, Shuang G. Zhao, Paul Lloyd, Rahul Aggarwal, Joshi J. Alumkal, Adam Foye, Vishal Kothari, Marc D. Perry, Adina M. Bailey, Denise Playdle, ...> ;Cell. 2018 Oct 18
• Associations between PET Amyloid Pathology and DTI Brain Connectivity in Preclinical Alzheimer's Disease.
  Hwang, S. J.,Adluru, N.,Kim, W. H.,Johnson, S.,Bendlin, B. B.,Singh, V.> ;Brain Connect. 2018 Sep 27
• Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
  Tomasz M Beer, Li Zhang, Robert E Reiter, Shuang G Zhao, Scott A Tomlins, John Shon, Arul M Chinnaiyan, Felix Y Feng, Won Kim, Joshua M Stuart, Rahul Aggarwal, Jonatha...> ;Cell Press. 2018 Jul 24
• 2 citations
  End-Stage Liver Disease in Patients with Intracranial Hemorrhage Is Associated with Increased Mortality: A Cohort Study.
  Carlito Lagman, Daniel T. Nagasawa, John P. Sheppard, Cheng Hao Jacky Chen, Thien Nguyen, Giyarpuram N. Prashant, Tianyi Niu, Alexander M. Tucker, Won Kim, Nader Poura...> ;World Neurosurgery. 2018 May 1
• 66 citations
  Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostat...
  Rahul Aggarwal, Xiao Wei, Won Kim, Eric J. Small, Charles J. Ryan, Peter R. Carroll, Matthew R. Cooperberg, Michael J. Evans, Thomas A. Hope> ;European Urology Oncology. 2018 May 1
• A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant P...
  Wei, X. X.,Siegel, A. P.,Aggarwal, R.,Lin, A. M.,Friedlander, T. W.,Fong, L.,Kim, W.,Louttit, M.,Chang, E.,Zhang, L.,Ryan, C. J.> ;Oncologist. 2018 Mar 01
• 107 citations
  Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond
  Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang> ;Journal for Immunotherapy of Cancer. 2018 Jan 25
• 12 citations
  Diffusion tractography imaging-guided frameless linear accelerator stereotactic radiosurgical thalamotomy for tremor: case report.
  Won Kim, Justin Sharim, Stephen Tenn, Tania Kaprealian, Yvette Bordelon, Nzhde Agazaryan, Nader Pouratian> ;Journal of Neurosurgery. 2018 Jan 1
• 191 citations
  Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.
  Shuang G. Zhao, S. Laura Chang, Nicholas Erho, Menggang Yu, Jonathan Lehrer, Mohammed Alshalalfa, Corey Speers, Matthew R. Cooperberg, Won Kim, Charles J. Ryan, Robert...> ;JAMA Oncology. 2017 Dec 1
• 16 citations
  High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer
  Terence W. Friedlander, Julie N. Graff, Kreshnik Zejnullahu, Archana Anantharaman, Li Zhang, Rosa Paz, Gayatri Premasekharan, Carly Russell, Yong Huang, Won Kim, Rahul...> ;Clinical Genitourinary Cancer. 2017 Dec 1
• 188 citations
  Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors.
  David A. Quigley, Joshi J. Alumkal, Alexander W. Wyatt, Vishal Kothari, Adam Foye, Paul Lloyd, Rahul Aggarwal, Won Kim, Eric Lu, Jacob Schwartzman, Kevin Beja, Matti A...> ;Cancer Discovery. 2017 Sep 1
• 426 citations
  Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
  Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Sam B. Bhayani, William P Bro, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar Derweesh, Mayer Fishman, Thoma...> ;Journal of the National Comprehensive Cancer Network. 2017 Jun 1
• 41 citations
  A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer
  Xiao X. Wei, Andrew C. Hsieh, Won Kim, Terence W. Friedlander, Amy M. Lin, Mirela Louttit, Charles J. Ryan> ;The Oncologist. 2017 May 1
• 8 citations
  A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A depart...
  Rahul Aggarwal, Alan H. Bryce, Charles J. Ryan, Andrea L. Harzstark, Christina Louise Derleth, Won Kim, Terence W. Friedlander, Amy M. Lin, Li Zhang, Mina Lee, Eric T ...> ;Urologic Oncology. 2017 Apr 1
• 1 citations
  Can Prostate Cancer Really Respond to Immunotherapy
  Won Kim, Lawrence Fong> ;Journal of Clinical Oncology. 2017 Jan 1
• 112 citations
  IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.
  Xiaoran Zhang, Aparana Rao, Paola Sette, Christopher P Deibert, Alexander Pomerantz, Wi Jin Kim, Gary Kohanbash, Yigang Chang, Yongseok Park, Johnathan A. Engh, Jaehyu...> ;Neuro-Oncology. 2016 Oct 1
• 2 citations
  Use of androgen receptor signaling- targeted therapies in chemotherapy-naive metastatic castration-resistant prostate cancer: a call for patient-centered studies
  Won Kim, Charles J. Ryan> ;Journal of Comparative Effectiveness Research. 2016 Jan 1
• 34 citations
  Cell type–specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitors
  Andrew C. Hsieh, Hao G. Nguyen, Lexiaochuan Wen, Merritt Edlind, Peter R. Carroll, Won Kim, Davide Ruggero> ;Science Signaling. 2015 Nov 17
• Join now to see all